A case of drug eruption with periorbital edema and exfoliative dermatitis induced by imatinib mesylate (STI571, Gleevec™)

Korean Journal of Dermatology

Volumn 45, Issue 2, 2007, Pages 194-196

  Young, Hyun Joo ^a   Seong, Uk Min ^a   Dong, Hin Lee ^a   Dae, Hun Suh ^a  

^a Seoul National University   (South Korea)

Author keywords

Drug eruption; Exfoliative dermatitis; Imatinib mesylate; Periorbital edema; STI571

Indexed keywords

EID: 34249711371     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Druker BJ, Talpez M, Resta D, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001:344:1031-1037
2. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344: 1038-1042
3. Hsiao LT, Chung HM, Lin JT, Chiou TJ, Liu JH, Fan FS, et al. Stevens-Johnson syndrome after treatment with STI571. Br J Haematol 2002;117:620-622
4. Brouard MC, Prins C, Mach-Pascual S, Saurat JH. Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology 2001;203:57-59
5. Konstantopoulos K, Papadogianni A, Dimopoulou M, Kourelis C, Meletis J. Pityriasis rosea associated with imatinib. Dermatology 2002;205:172-173
6. Esmaeli B, Prieto VG, Butler CE, Kim SK, Ahmadi MA, Kantarjian HM, et al. Severe periorbital edema secondary to STI571. Cancer 2002;95:881-887
7. Pietras K, Ostman A, Sjoquist M, Buchdunger E, Reed RK, Heldin CH, et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res 2001;61: 2929-2934
8. Oh CS, Park HJ, Lee JY, Cho BK, Kim DW, Kim CC. A clinical and histopathological study of drug eruptions caused by STI571. Korean J Dermatol 2003;41:1291-1296
9. Simon AJR, Stephen GO, Lucy CCM. Managing cutaneous reactions to imatinib therapy. Blood 2002;100:3434-3435